Citations

Clear

1792 citation(s) found for "Stephanie".

Elbow Torque May be Predictive of Anatomic Adaptations to the Elbow After a Season of Collegiate Pitching: A Dynamic Ultrasound Study
Khalil, Lafi S. , Jildeh, Toufic R. , Klochko, Chad , Scher, Courtney, Muh, Stephanie , Moutzouros, Vasilios , Okoroha, Kelechi R. , Abbas, Muhammad J. , Holsbeeck, Marnix van , Makhni, Eric Chugh

Mayo Clinic

Arthroscopy, Sports Medicine, and Rehabilitation | October 12, 2021 | Volume: 3 | Issue: 6 | Pages: No page available

10.1016/j.asmr.2021.08.012 | PMID 34977639 Get It

Purpose To determine whether elbow torque was associated with anatomic adaptations of the medial elbow following a season of competitive pitching. Methods Pitchers from 3 collegiate baseball teams were recruited during the preseason for participation. Before the season, pitchers were recorded throwing 5 “game‐speed” fastball pitches from a standard distance off a mound while wearing a wearable sensor baseball compression sleeve that calculates elbow torque, arm speed, arm slot, and arm rotation. Participants subsequently underwent dynamic ultrasound imaging of the medial elbow, including measurements of the ulnar collateral ligament (UCL) and ulnohumeral joint space to assess elbow laxity. Following a full season of competitive pitching, all testing was repeated, and statistical analysis comparing preseason to postseason sonographic findings was performed. Results Twenty‐eight collegiate pitchers underwent preseason sonographic and kinematic testing. Nineteen pitchers were available for postseason testing. The average age (standard deviation) and playing experience was 19.9 (1.2) and 14.7 (1.5) years. Compared with preseason, there were significant increases in postseason UCL thickness (1.92 ± 0.09 vs 1.56 ± 0.09 mm, P < .01) and elbow laxity (1.77 ± 0.23 vs 1.15 ± 0.22 mm, P = .028) after a season of pitching. No significant changes in pitching kinematic measurements were observed between preseason and postseason testing. Preseason pitching kinematic measurements were significantly associated with increased UCL thickness (arm slot: beta estimate –0.03 ± 0.01, P = .011) and reduction in elbow laxity (elbow torque: beta estimate –0.03 ± 0.01, P = .04) after a season of pitching. Pitchers with increased body weight and arm length demonstrated reduced medial elbow torque during pitching ( P < .05). Conclusions After a season of competitive pitching, adaptive changes of the medial elbow were demonstrated on dynamic ultrasound. However, the influence of pitching kinematic measurements on these adaptations are of small magnitude and unknown clinical significance. Although wearable sensor technology may have value in trending individual pitcher kinematics, no discrete threshold appears to predict the development of adaptive changes at the elbow. Level of Evidence Level II, prospective observational study.
Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Management of Tick-Borne Illness in the United States
Ho, Benjamin M., Davis, Hillary E. , Haston, Taylor, Sanders, Linda, Lee, Mary Caroll, Lareau, Stephanie , Caudell, Michael, Davis, Christopher , Sheele, Johnathan M. , Forrester, Joseph D. , Sanders, Linda

Mayo Clinic

Wilderness & Environmental Medicine | October 12, 2021 | Volume: 32 | Issue: 4 | Pages: 474-494

10.1016/j.wem.2021.09.001 | PMID 34642107 Get It

The Wilderness Medical Society convened an expert panel to develop evidence-based guidelines for the prevention and management of tick-borne illness (TBI). Recommendations are graded based on quality of supporting evidence according to criteria put forth by the American College of Chest Physicians. The guidelines include a brief review of the clinical presentation, epidemiology, prevention, and management of TBI in the United States, with a primary focus on interventions that are appropriate for resource-limited settings. Strong recommendations are provided for the use of DEET, picaridin, and permethrin; tick checks; washing and drying clothing at high temperatures; mechanical tick removal within 36 h of attachment; single-dose doxycycline for high-risk Lyme disease exposures versus “watchful waiting;” evacuation from backcountry settings for symptomatic tick exposures; and TBI education programs. Weak recommendations are provided for the use of light-colored clothing; insect repellents other than DEET, picaridin, and permethrin; and showering after exposure to tick habitat. Weak recommendations are also provided against passive methods of tick removal, including the use of systemic and local treatments. There was insufficient evidence to support the use of long-sleeved clothing and the avoidance of tick habitat such as long grasses and leaf litter. Although there was sound evidence supporting Lyme disease vaccination, a grade was not offered as the vaccine is not currently available for use in the United States.
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers
Weinberg, David S. , Foster, Nathan R. , Della’Zanna, Gary , Pallotto, Angela, Katz, Leo C., Henry, Christopher , Moleski, Stephanie , McMurray, Ryan P. , Limburg, Paul J. , Waldman, Scott A , Kraft, Walter K. , Kastenberg, David , Waldman, Scott A.

Mayo Clinic

Cancer Biology & Therapy | October 11, 2021 | Volume: 22 | Issue: 10-12 | Pages: 544-553

10.1080/15384047.2021.1967036 | PMID 34632925 Get It

243 Relationship Among Granulosa Cell Gnrh-i, -II, and Receptor Mrna Abundance and Follicular Fluid Steroid Hormone Concentrations of Bovine Antral Follicles at Specific Stages of Follicular Development
Northrop‐Albrecht, Emmalee J. , Epperson, Kaitlin M , Zoca, Saulo Menegatti , Perkins, Stephanie D., Daly, Russell F. , Cushman, Robert A. , Rich, Jerica J J , Perry, George A.

Mayo Clinic

Journal of Animal Science | October 8, 2021 | Volume: 99 | Issue: Supplement_3 | Pages: 126-127

10.1093/jas/skab235.230 Get It

Abstract Transcript abundance of two forms of GnRH and its receptor have been characterized in bovine ovaries. The objective was to investigate the relationship of GnRH-1, GnRH-2, GnRH-R, intrafollicular estradiol (E2) and progesterone (P4) during follicular development. Ovaries were collected from beef cows at specific stages of follicular development [pre-selection (PRE, n = 9), post-selection (POST, n = 9), and post-selection 24h after luteal regression (PG, n = 9)]. The largest follicle per stage was aspirated to obtain granulosa cells (GC) and follicular fluid (FF). Total cellular RNA was extracted from GC and RT-PCR was performed for GnRH-1, GnRH-2, GnRH-R and GAPDH. Radioimmunoassays were performed to determine FF concentrations of E2 and P4. Data were analyzed using the MIXED and REG procedures in SAS. There was no difference (P ≥ 0.23) in mRNA abundance of GnRH-2, GnRH-R or FF concentrations of P4 across follicular stages. There was an effect of stage on FF E2 (PRE: 17,925±20,273, POST: 28,458±21,503, and PG: 252,616±21,503 pg/mL; P &lt; 0.01). Stage affected GnRH-1 mRNA abundance (PRE: 2.28±0.55, POST: 0.92±0.55, and PG: 0.11±0.55; P = 0.03). There was no relationship of GnRH-1 and GnRH-2 mRNA abundance or effect of FF P4 on GnRH-R mRNA abundance (P ≥ 0.23). There was no effect of FF P4 on GnRH-1 mRNA abundance (P = 0.68). There was no effect of FF E2 on GnRH-2 mRNA abundance (P = 0.66). As FF E2 increased GnRH-R mRNA abundance tended to increase (P = 0.10;r2=0.13). As FF P4 concentrations increased GnRH-2 mRNA abundance tended to decrease (P = 0.09;r2=0.12). As FF E2 increased GnRH-1 mRNA abundance decreased (P = 0.02;r2=0.20). In conclusion, there were differences in peptide and receptor mRNA abundance of GnRH in relation to FF E2 and P4 at specific stages of follicular development. This is supportive of a regulatory relationship between ovarian GnRH and steroidogenesis. This work is supported by AFRI Grant No.2018-67016-27578 from USDA. USDA is an equal opportunity provider and employer.
Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future
Chowdhury, Devyani , Johnson, Jonathan N. , Baker‐Smith, Carissa M. , Jaquiss, Robert, Mahendran, Arjun , Curren, Valerie , Bhat, Aarti , Marshall, Audrey C. , Fuller, Stephanie , Marino, Bradley S. , Fink, Christina M. , Ather, Mishaal, Torentinos, Natalie, Kranz, Olivia, Thorne, Vivian, Berger, Stuart, Shaffer, Kenneth M. , Mahendran, Arjun K , Fink, Christina M , Lopez, Keila N , Baker-Smith, Carissa M , Jaquiss, Robert D.B. , Patel, Angira , Lopez, Keila N. , Frank, Lowell H. , Davies, Ryan R. , Snyder, Christopher, Saidi, Arwa S.

Mayo Clinic

Journal of the American Heart Association | October 8, 2021 | Volume: 10 | Issue: 20 | Pages: No page available

10.1161/jaha.120.020605 | PMID 34622676 Get It

Abstract The congenital heart care community faces a myriad of public health issues that act as barriers toward optimum patient outcomes. In this article, we attempt to define advocacy and policy initiatives meant to spotlight and potentially address these challenges. Issues are organized into the following 3 key facets of our community: patient population, health care delivery, and workforce. We discuss the social determinants of health and health care disparities that affect patients in the community that require the attention of policy makers. Furthermore, we highlight the many needs of the growing adults with congenital heart disease and those with comorbidities, highlighting concerns regarding the inequities in access to cardiac care and the need for multidisciplinary care. We also recognize the problems of transparency in outcomes reporting and the promising application of telehealth. Finally, we highlight the training of providers, measures of productivity, diversity in the workforce, and the importance of patient–family centered organizations in advocating for patients. Although all of these issues remain relevant to many subspecialties in medicine, this article attempts to illustrate the unique needs of this population and highlight ways in which to work together to address important opportunities for change in the cardiac care community and beyond. This article provides a framework for policy and advocacy efforts for the next decade.
Modulation of fracture healing by the transient accumulation of senescent cells
Saul, Dominik , Rowsey, Jennifer L. , Kosinsky, Robyn Laura , Vos, Stephanie J. B. , Farr, Joshua N. , Khosla, Sundeep , Vos, Stephanie J, Doolittle, Madison L. , Farr, Joshua N , Khosla, Sundeep , Kosinsky, Robyn Laura , Saul, Dominik , Monroe, David G. , Vos, Stephanie J

Mayo Clinic

eLife | October 7, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.7554/elife.69958 | PMID 34617510 Get It

Senescent cells have detrimental effects across tissues with aging but may have beneficial effects on tissue repair, specifically on skin wound healing. However, the potential role of senescent cells in fracture healing has not been defined. Here, we performed an in silico analysis of public mRNAseq data and found that senescence and senescence-associated secretory phenotype (SASP) markers increased during fracture healing. We next directly established that the expression of senescence biomarkers increased markedly during murine fracture healing. We also identified cells in the fracture callus that displayed hallmarks of senescence, including distension of satellite heterochromatin and telomeric DNA damage; the specific identity of these cells, however, requires further characterization. Then, using a genetic mouse model ( Cdkn2a LUC ) containing a Cdkn2a Ink4a -driven luciferase reporter, we demonstrated transient in vivo senescent cell accumulation during callus formation. Finally, we intermittently treated young adult mice following fracture with drugs that selectively eliminate senescent cells (‘senolytics’, Dasatinib plus Quercetin), and showed that this regimen both decreased senescence and SASP markers in the fracture callus and significantly accelerated the time course of fracture healing. Our findings thus demonstrate that senescent cells accumulate transiently in the murine fracture callus and, in contrast to the skin, their clearance does not impair but rather improves fracture healing.
Proposed research criteria for prodromal behavioural variant frontotemporal dementia
Barker, Megan S. , Gottesman, Reena , Manoochehri, Masood , Chapman, Silvia , Brushaber, Danielle , Devick, Katrina L. , Domoto‐Reilly, Kimiko , Fields, Julie A. , Forsberg, Leah K. , Ghoshal, Nupur , Graff‐Radford, Neill R. , Heuer, Hilary W. , Kornak, John , Mackenzie, Ian R. , Masdeu, Joseph C. , Mendez, Mario F, Pascual, Belén , Staffaroni, Adam M. , Tartaglia, Maria Carmela , Boxer, Adam L. , Rosen, Howard J. , Rankin, Katherine P. , Cosentino, Stephanie , Rascovsky, Katya, Huey, Edward D. , Kaufer, Daniel , Onyike, Chiadi U. , Ritter, Aaron, Weıntraub, Sandra , Devick, Katrina L , Masdeu, Joseph C , Pascual, Belen , Boeve, Brad , Tartaglia, Maria Carmela , Domoto-Reilly, Kimiko , Appleby, Brian S. , Dickerson, Bradford Clark , Galasko, Douglas , Goldman, Jill , Grossman, Murray , Hsiung, Ging‐Yuek Robin , Knopman, David S. , Litvan, Irene , Mendez, Mario F, Boeve, Bradley F. , Foroud, Tatiana , Kremers, Walter K. , Léger, Gabriel C. , Roberson, Erik D.

Mayo Clinic

Brain | September 30, 2021 | Volume: 145 | Issue: 3 | Pages: 1079-1097

10.1093/brain/awab365 | PMID 35349636 Get It

Abstract At present, no research criteria exist for the diagnosis of prodromal behavioural variant frontotemporal dementia (bvFTD), though early detection is of high research importance. Thus, we sought to develop and validate a proposed set of research criteria for prodromal bvFTD, termed ‘mild behavioural and/or cognitive impairment in bvFTD’ (MBCI-FTD). Participants included 72 participants deemed to have prodromal bvFTD; this comprised 55 carriers of a pathogenic mutation known to cause frontotemporal lobar degeneration, and 17 individuals with autopsy-confirmed frontotemporal lobar degeneration. All had mild behavioural and/or cognitive changes, as judged by an evaluating clinician. Based on extensive clinical workup, the prodromal bvFTD group was divided into a Development Group (n = 22) and a Validation Group (n = 50). The Development Group was selected to be the subset of the prodromal bvFTD group for whom we had the strongest longitudinal evidence of conversion to bvFTD, and was used to develop the MBCI-FTD criteria. The Validation Group was the remainder of the prodromal bvFTD group and was used as a separate sample on which to validate the criteria. Familial non-carriers were included as healthy controls (n = 165). The frequencies of behavioural and neuropsychiatric features, neuropsychological deficits, and social cognitive dysfunction in the prodromal bvFTD Development Group and healthy controls were assessed. Based on sensitivity and specificity analyses, seven core features were identified: apathy without moderate-severe dysphoria, behavioural disinhibition, irritability/agitation, reduced empathy/sympathy, repetitive behaviours (simple and/or complex), joviality/gregariousness, and appetite changes/hyperorality. Supportive features include a neuropsychological profile of impaired executive function or naming with intact orientation and visuospatial skills, reduced insight for cognitive or behavioural changes, and poor social cognition. Three core features or two core features plus one supportive feature are required for the diagnosis of possible MBCI-FTD; probable MBCI-FTD requires imaging or biomarker evidence, or a pathogenic genetic mutation. The proposed MBCI-FTD criteria correctly classified 95% of the prodromal bvFTD Development Group, and 74% of the prodromal bvFTD Validation Group, with a false positive rate of &lt;10% in healthy controls. Finally, the MBCI-FTD criteria were tested on a cohort of individuals with prodromal Alzheimer’s disease, and the false positive rate of diagnosis was 11–16%. Future research will need to refine the sensitivity and specificity of these criteria, and incorporate emerging biomarker evidence.
The effect of omega-3 fatty acids on a biomarker of head trauma in NCAA football athletes: a multi-site, non-randomized study
Anzalone, Anthony J. , Carbuhn, Aaron F. , Askow, Andrew T. , Stone, Jason D. , Turner, Stephanie M., Hillyer, Lyn M., Luedke, Joel, Oliver, Jonathan M. , Anzalone, Anthony J , Askow, Andrew T , Heileson, Jeffery L. , W.L., David , Jagim, Andrew R.

Mayo Clinic

Journal of the International Society of Sports Nutrition | September 27, 2021 | Volume: 18 | Issue: 1 | Pages: No page available

10.1186/s12970-021-00461-1 | PMID 34579748 Get It

Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Brown, Patrick A. , Aoun, Patricia, Boyer, Michael W., Burke, Patrick W. , Dinner, Shira, Fathi, Amir T. , Kirby, Suzanne, Liedtke, Michaela , Litzow, Mark R. , Luger, Selina M. , Maness, Lori J., Massaro, Stephanie, Mattison, Ryan J. , May, William , Oluwole, Olalekan O. , Park, Jae H. , Uy, Geoffrey L. , Vusirikala, Madhuri , Wieduwilt, Matthew J. , Lynn, Beth, Berardi, Ryan A., Freedman-Cass, Deborah A., Campbell, Mallory, Oluwole, Olalekan O , Uy, Geoffrey , Shah, Bijal , Advani, Anjali S. , DeAngelo, Daniel J. , Gauthier, Jordan , Jain, Nitin , Logan, Aaron C , Przespolewski, Amanda , Rangaraju, Sravanti , Rubnitz, Jeffrey E.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | September 22, 2021 | Volume: 19 | Issue: 9 | Pages: 1079-1109

10.6004/jnccn.2021.0042 | PMID 34551384 Get It

The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. Given the complexity of ALL treatment regimens and the required supportive care measures, the NCCN ALL Panel recommends that patients be treated at a specialized cancer center with expertise in the management of ALL This portion of the Guidelines focuses on the management of Ph-positive and Ph-negative ALL in adolescents and young adults, and management in relapsed settings.